Allianz Asset Management
ANIK icon

Allianz Asset Management’s Anika Therapeutics ANIK Stock Holding History

Allianz Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,270
Closed -$803K – 2610
2017
Q2 		$803K Sell
16,270
-29,672
-65% -$1.37M ﹤0.01% 2286
2017
Q1 		$2M Buy
45,942
+7,825
+21% +$374K ﹤0.01% 2005
2016
Q4 		$1.87M Buy
38,117
+2,489
+7% +$115K ﹤0.01% 1998
2016
Q3 		$1.71M Buy
+35,628
New +$1.76M ﹤0.01% 2044
2015
Q2 		– Sell
-285,408
Closed -$11.8M – 2366
2015
Q1 		$11.8M Sell
285,408
-85,963
-23% -$3.48M 0.01% 881
2014
Q4 		$15.1M Sell
371,371
-15,758
-4% -$616K 0.02% 810
2014
Q3 		$14.2M Buy
387,129
+4,588
+1% +$198K 0.02% 736
2014
Q2 		$17.7M Sell
382,541
-38,944
-9% -$1.73M 0.02% 595
2014
Q1 		$17.3M Buy
421,485
+115,624
+38% +$4.3M 0.02% 589
2013
Q4 		$11.7M Buy
305,861
+23,814
+8% +$735K 0.01% 678
2013
Q3 		$6.76M Buy
282,047
+31,747
+13% +$713K 0.01% 821
2013
Q2 		$4.25M Buy
+250,300
New +$3.61M 0.01% 944

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Allianz Asset Management's ANIK Position: Q3 2017 in Review

Allianz Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2017, closing a stake of 16,270 shares — an estimated $803K sold.

Allianz Asset Management first reported a position in ANIK in Q2 2013 and held it in 12 quarters. The position peaked at $17.7M in Q2 2014. 166 funds tracked by Wall St. Rank hold ANIK as of Q3 2017.

  • Allianz Asset Management reported no remaining Anika Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Allianz Asset Management sold 16,270 Anika Therapeutics shares in Q3 2017, an estimated $803K.
  • Allianz Asset Management first reported a position in Anika Therapeutics in Q2 2013 and held it in 12 quarters.
  • Allianz Asset Management's Anika Therapeutics position peaked at $17.7M in Q2 2014.
  • 166 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2017.

Based on Allianz Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.